Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-25 @ 12:03 PM
NCT ID:
NCT04074161
Group ID:
EG000
Title:
Semaglutide 2.4 mg
Description:
The trial included an initial dose-escalation period during which the dose was gradually increased (0.24, 0.5, 1.0, 1.7 milligram (mg)) to the maintenance dose of semaglutide 2.4 mg once weekly (16-week dose-escalation period). After the dose escalation period, treatment continued on the maintenance dose up to week 68 (end of treatment). In week 44, all participants switched from the PDS290 pen-injector to the DV3396 single-dose pen-injector. A follow-up visit (end of trial) for safety assessments was scheduled 7 weeks after end of treatment.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
10
Serious Number At Risk:
126
Other Number Affected:
115
Other Number At Risk:
126
Study:
NCT04074161
Results Section:
NCT04074161
Adverse Events Module:
NCT04074161